Promedius Inc.

📍 Seoul, South Korea🗓 Founded 2019👥 15 employees💰 Last funded Jun 2020
Medical Device🌐 promedius.ai
Website LinkedIn
With unsupervised AI technologies, we aim to provide safe and reliable AI solutions into clinical workflow -- End-to-end AI Solutions in Medical Imaging A. Image Reconstruction Solutions - CT-denoising/MRI acceleration/Image neutralization B. Image Diagnosis Solutions Anomaly detection in CT/MR/X-ray, CBIR (Content-based Image Retrieval) C. Image Generation Solutions Privacy-preserving high-quality medical images -- Discover how we fight COVID-19 with our AI solutions PROS CXR: COVID-19 (not approved) - AI-based COVID-19 diagnosis solution on CXRs - Collaboration with KAIST, Korea - Classify CXRs into 4 classes with high accuracy: Normal, bacterial pneumonia, tuberculosis, and viral pneumonia including COVID-19 - On-Premise standalone or cloud-based solutions are available with native DICOM/DICOMweb protocol supports Real-time anonymization, TLS-encrypted secured connection, and image sharing functionality in our cloud-based solution
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
South Korea
1
Frequently asked questions
Who invested in Promedius Inc.?
Promedius Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Promedius Inc. last raise funding?
The most recent investment in Promedius Inc. recorded on gritt.io was in June 2020.
When was Promedius Inc. founded?
Promedius Inc. was founded in 2019.
What industry is Promedius Inc. in?
Promedius Inc. operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is Promedius Inc. based?
Promedius Inc. is headquartered in Seoul, South Korea.